Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Prepare for unexpected expenses by outlining scenarios, creating buffers, and scheduling regular budget checks for adjustments.
13,762 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A new Morgan Stanley analysis says Europe trails the United States in AI spending, with seven U.S. hyperscalers expec...
The U.S. government has expanded direct stakes in select public firms, tying national security goals to market moves ...
A December 2025 Florida Tax Watch study identifies the ten Florida counties with the lowest property taxes, led by Un...
Investing in rare earths is a long game tied to U.S. policy, global demand, and the pace of production. This guide co...
Markets steadied after the Supreme Court struck down sweeping tariffs, a move largely priced in by investors. Wall St...
The AI era has reshaped Palantir's role in enterprise data. This guide weighs the buy, sell, hold case for 2026 with ...
KBR faced a two-sided story: a massive backlog that hints at strong future demand, and a prominent investor trimming ...
Investors want to know if now is the time figma stock? This guide breaks down how to evaluate Figma stock, what metri...
Investors are focusing on the links between battlefield tech and defense earnings as analysts highlight the firearms ...
An in-depth look at Warner Bros. Discovery (WBD) earnings, how its streaming ambitions intersect with legacy TV, and ...
Dell Technologies posted a billion-dollar quarter, driven by AI server orders that surged in Q4 and propelled a raise...